Bhubaneswar: The Institute of Life Science (ILS), Bhubaneswar, has been chosen as one of the 16 biorepository centres in the country for COVID-19 clinical samples.
The government of India is looking to increase research and development efforts in order to create new diagnostics, therapeutics and vaccines in the future. The repository will collect, store and maintain clinical samples (oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool) of coronavirus patients.
The institute will be authorized to share these samples with academia, industry and commercial entities involved in development of diagnostics, therapeutics, vaccines after scrutinization. The purpose of sharing clinical specimens and the intended use will be examined by the National Oversight Committee as well as the Institutional Human Ethics Committee.
New Delhi: Folk singer Sharda Sinha, who was admitted to AIIMS due to complications related…
Jeypore: A 24-year-old inconsolable man, rolling on the ground unable to bear the loss of…
New Delhi: A five-judge Constitution bench of the Supreme Court on Wednesday ruled that a…
Bhubaneswar: Two persons died while another sustained critical injuries as the car in which they…
New Delhi: Tens of millions of Americans are choosing between two candidates with vastly different…
Berhampur: Unidentified miscreants decamped with gold and silver jewellery worth lakhs of rupees and all…
Bhubaneswar: The Odisha Vigilance sleuths on Wednesday carried out raids on properties linked to Junior…
Bhubaneswar: A massive fire broke out at the studio of a private TV channel at…